The best indicator for Waters Corporation (WAT)
We backtested 20 indicators across daily, weekly and hourly charts on real Waters Corporation (WAT) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Williams %R
On the daily chart, this is the strongest risk-adjusted edge we found for Waters Corporation (WAT) over ~30.5 years — trailing buy-and-hold by 4.6% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Williams %R ✓ | Daily | 11.6% | 0.56 | -69.4% | 74.6% | 213 | -4.6% |
| 2 | RSI Mean-Reversion ✓ | Daily | 7.2% | 0.52 | -43.4% | 77.8% | 45 | -9.0% |
| 3 | Stochastic ✓ | Daily | 8.9% | 0.47 | -60.4% | 74.3% | 152 | -7.3% |
| 4 | Stochastic ✓ | Weekly | 7.5% | 0.46 | -56.8% | 79.3% | 29 | -8.6% |
| 5 | EMA 20/50 Cross ✓ | Daily | 8.5% | 0.45 | -60.8% | 47.7% | 65 | -7.6% |
| 6 | CCI ✓ | Daily | 8.2% | 0.44 | -55.7% | 72.2% | 151 | -8.0% |
| 7 | WaveTrend (8/6/4) ✓ | Daily | 8.7% | 0.44 | -69.4% | 76.1% | 109 | -7.4% |
| 8 | RSI Trend (>50) | Weekly | 8.1% | 0.43 | -58.1% | 49.4% | 83 | -8.0% |
| 9 | WaveTrend (8/6/4) ✓ | Weekly | 7.8% | 0.42 | -62.3% | 91.3% | 23 | -8.3% |
| 10 | ADX / DMI | Weekly | 6.7% | 0.4 | -53.3% | 45.8% | 48 | -9.3% |
| 11 | MACD ✓ | Weekly | 6.4% | 0.38 | -73.5% | 52.7% | 55 | -9.6% |
| 12 | Donchian Midline | Weekly | 6.6% | 0.38 | -67.3% | 46.5% | 71 | -9.5% |
| 13 | Holy Grail Confluence ✓ | Daily | 5.6% | 0.37 | -64.7% | 74.5% | 47 | -10.5% |
| 14 | EMA 20/50 Cross | Weekly | 6.7% | 0.37 | -65.0% | 47.1% | 17 | -9.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Waters Corporation (WAT), Williams %R on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.